Clinical trials recruiting for Gastric Cancer (GC)
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| H2 receptor antagonist | 1 |
| ICG fluorescence imaging technology | 1 |
| OKN4395 | 1 |
| Pembrolizumab | 1 |
| SH009 | 1 |
| THE-0504 | 1 |
| XH001 Injection | 1 |
| [68Ga]BED003 | 1 |
| mFOLFIRINOX Treatment Regimen | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| California | 2 |
| Texas | 1 |
Top cities
Self-screener
Recruiting trials
- A Noninvasive and Screening miRNA Signature for Gastrointestinal Cancer
- A Phase 1, First-in-human Study of OKN4395 and Pembrolizumab in Patients With Solid Tumors
- A Study of SH009 Injection in Patients With Advanced Solid Tumors.
- PPG vs. ICG in Gastrointestinal Resections
- THE-0504 in Patients With Solid Tumors
- To Evaluate the Safety, Tolerability, and Preliminary Efficacy of XH001 Injection as Adjuvant Therapy in Patients With High-risk Recurrent Solid Tumors
- [68Ga]BED003 PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications
Related conditions
Trials recruiting for Gastric Cancer (GC) often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Gastric Cancer (GC) trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.